27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

FACILITIES: 495,623 sq. ft. of active laboratory space<br />

STOCK-FINANCIAL HISTORY: Government agency<br />

SUBSIDIARIES/DIVISIONS: Environmental Molecular Sciences Laboratory<br />

Marine Sciences Laboratory<br />

BUSINESS STRATEGY: VISION: To be recognized worldwide and valued regionally for leadership in<br />

rapidly translating discoveries into solutions. . . for challenges in energy,<br />

national security and the environment. . .by integrating the chemical,<br />

physical and biological sciences<br />

MISSION: Perform basic and applied research to deliver energy,<br />

environmental and national security for the nation<br />

AGREEMENTS: Name Products Content of Agreement Date<br />

Micell<br />

Technologies<br />

use of supercritical<br />

fluids for the creation of<br />

medical device surface<br />

modifications<br />

RESEARCH & DEVELOPMENT: More than 100 ongoing R&D projects annually<br />

Pall Corp.<br />

2200 Northern Boulevard<br />

East Hills NY 11548-1248, US<br />

Phone: (516) 484-5400; Fax: (516) 484-5228<br />

Toll-free phone: (800) 645-6532<br />

Web: www.pall.com; E-mail: info@pall.com<br />

research and<br />

licensing<br />

collaboration,<br />

expanded 8/06<br />

KEY PERSONNEL: Eric Krasnoff; Chairman and CEO<br />

Marc Wilson; President<br />

Lisa McDermott; CFO<br />

Donald Stevens; COO and President, Pall Industrial<br />

Steven Chisholm; Sr. VP and President, Microelectronics Group<br />

Roberto Perez; Sr. VP and President, Pall Life Sciences<br />

Jim Western; Sr. VP and President, Aerospace Group<br />

EMPLOYEES: 10,700 employees<br />

HISTORY: Founded in July 1946<br />

Acquired Gelman Sciences (2/97)<br />

Acquired Rochem Environmental (1/98)<br />

Acquired the Filtration and Separations Group (2002)<br />

Acquired BioSerpa process chromatography business from Ciphergen<br />

Biosystems Inc. (11/04)<br />

FACILITIES: Offices and plants throughout the world<br />

STOCK-FINANCIAL HISTORY: NYSE—Pll<br />

Net sales $1.902b (YE 05) compared to $1.771b (YE 04)<br />

Net income $140.8M (YE 05) compared to $1.121/share (YE 04)<br />

Total assets $2.265b (YE 05) compared to $2.183 (YE 04)<br />

SUBSIDIARIES/DIVISIONS: Life Sciences business—<strong>Medical</strong>, Biopharmaceuticals, Laboratory<br />

Industrial business—General Industrial, Aerospace and Microelectronics,<br />

Food & Beverage<br />

BUSINESS STRATEGY: Pursue Growth through aggressive R&D approach that advances company’s<br />

products and creates niche applications across many markets, industries<br />

and geographies<br />

PRODUCTS ON MARKET: Filtration, separation and purification systems for total fluid management in<br />

the industrial and life sciences markets<br />

Copyright ©2006 AHC Media ® 294

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!